EUDA Health Holdings Limited (EUDA) shares rose 28.31 percent, or $0.39, to $1.75 on Tuesday, after the company announced a major acceleration of its longevity and regenerative medicine strategy, including the launch of a comprehensive stem cell therapy platform and the establishment of its first clinic in Shenzhen, China.
Shares were trading at $1.75, up from a previous close of $1.36 on the Nasdaq. The stock opened at $1.39 and moved within a day's range of $1.39 to $2.19. Trading volume reached about 4.22 million shares, well above the average volume of roughly 97,700 shares.
EUDA Health Holdings has a 52-week trading range of $1.03 to $4.70.
For comments and feedback contact: editorial@rttnews.com
Business News
December 19, 2025 15:10 ET U.S. inflation data and interest rate decisions by major central banks were the highlights of this busy week for economics news flow. Employment data and survey results on the housing markets also gained attention in the U.S. In Europe, the European Central Bank and Bank of England announced their policy decisions and macroeconomic projections.